Entera Bio Ltd. (ENTX)
2.84
-0.17
(-5.65%)
USD |
NASDAQ |
Sep 09, 16:00
2.84
0.00 (0.00%)
After-Hours: 17:07
Entera Bio Total Liabilities (Quarterly) : 12.21M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.21M |
| March 31, 2026 | 2.442M |
| December 31, 2025 | 2.892M |
| September 30, 2025 | 2.173M |
| June 30, 2025 | 2.411M |
| March 31, 2025 | 2.221M |
| December 31, 2024 | 1.31M |
| September 30, 2024 | 1.289M |
| June 30, 2024 | 1.503M |
| March 31, 2024 | 1.376M |
| December 31, 2023 | 1.379M |
| September 30, 2023 | 2.329M |
| June 30, 2023 | 2.213M |
| March 31, 2023 | 1.526M |
| December 31, 2022 | 1.373M |
| September 30, 2022 | 1.228M |
| June 30, 2022 | 1.819M |
| March 31, 2022 | 2.567M |
| December 31, 2021 | 3.422M |
| Date | Value |
|---|---|
| September 30, 2021 | 3.134M |
| June 30, 2021 | 3.624M |
| March 31, 2021 | 10.91M |
| December 31, 2020 | 2.212M |
| September 30, 2020 | 3.04M |
| June 30, 2020 | 4.233M |
| March 31, 2020 | 5.168M |
| December 31, 2019 | 4.784M |
| September 30, 2019 | 3.285M |
| June 30, 2019 | 2.583M |
| March 31, 2019 | 3.743M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 44.84M |
| September 30, 2017 | 32.86M |
| June 30, 2017 | 30.42M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioLineRx Ltd. | 16.86M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 113.60M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 5.545M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.48M |
| Shareholders Equity (Quarterly) | 7.266M |
| Debt to Equity Ratio | 0.0585 |
| Current Ratio | 8.981 |
| Net Debt Paydown Yield | -0.05% |